Changing trends in antimicrobial resistance of Salmonella enterica serovar typhi and Salmonella enterica serovar paratyphi A in Chennai

被引:25
|
作者
Krishnan, Padma [1 ]
Stalin, M. [1 ]
Balasubramanian, S. [2 ]
机构
[1] Univ Madras, Dept Microbiol, Dr ALM Post Grad Inst Basic Med Sci, Madras 600113, Tamil Nadu, India
[2] Kanchi Kamakoti CHILDS Trust Hosp, Madras, Tamil Nadu, India
关键词
Chloramphenicol; fluoroquinolones; multi-drug-resistant Salmonella; nalidixic acid; SEROTYPE TYPHI; MULTIDRUG-RESISTANCE; KOLKATA;
D O I
10.4103/0377-4929.56140
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background and Objectives: Chloramphenicol was considered the antimicrobial gold standard for typhoid treatment but, following the increasing worldwide frequency of antibiotic resistance, ciprofloxacin has been the mainstay of therapy since 1980. Recent studies have shown a shifting of susceptibility to conventional drugs like chloramphenicol, ampicillin and cotrimoxazole. The primary objective of the study was to evaluate the in vitro activity of chloramphenicol and other first-line drugs in comparison with cephalosporins and quinolones. Materials and Methods: Fifty isolates of Salmonella obtained from blood culture were subjected to serotyping at the Central Research Institute, Kasauli. Phage typing and biotyping was performed at the National Phage Typing Centre, New Delhi. Antibiotic sensitivity testing was carried out for 10 drugs by the Kirby-Bauer disc diffusion method and minimum inhibitory concentration by broth microdilution for nalidixic acid, chloramphenicol, ciprofloxacin, ceftriaxone, cefixime and ofloxacin. Multi-drug-resistant (MDR) strains were checked for plasmid. Results: In the present study, 70 and 30% of the isolates were Salmonella enterica serovar typhi and paratyphi A, respectively. They were highly sensitive to chloramphenicol (86%), ampicillin (84%) and cotrimoxazole (88%). Highest sensitivity was seen for cephalosporins, followed by quinolones. Seventeen/21 (81%) and 100% of the Salmonella enterica serovar typhi strains belonged to E1 phage type and biotype 1, respectively. Antibiogram showed 2% of the strains to be sensitive to all the drugs tested and 12% were MDR and showed the presence of plasmids. Conclusion: The study indicates reemergence of chloramphenicol-susceptible Salmonella enterica serovar typhi and paratyphi A isolates, a significant decline in MDR strains and high resistance to nalidixic acid. E1 phage type and biotype 1 are found to be most prevalent in Chennai, India.
引用
收藏
页码:505 / 508
页数:4
相关论文
共 50 条
  • [1] Distinct Potentially Adaptive Accumulation of Truncation Mutations in Salmonella enterica serovar Typhi and Salmonella enterica serovar Paratyphi A
    Robinson, Stephy Mol
    Rajachandran, Vyshakh
    Majumdar, Suchismita
    Saha, Satabdi
    Das, Sneha
    Chattopadhyay, Sujay
    MICROBIOLOGY SPECTRUM, 2022, 10 (03):
  • [2] Understanding the Mechanism of Antimicrobial Resistance and Pathogenesis of Salmonella enterica Serovar Typhi
    Khan, Maryam
    Shamim, Saba
    MICROORGANISMS, 2022, 10 (10)
  • [3] Characterization of antimicrobial resistance markers & their stability in Salmonella enterica serovar Typhi
    Kumar, Yashwant
    Sharma, Anshu
    Mani, Kavaratty Raju
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2017, 146 : 9 - 14
  • [4] The genome of Salmonella enterica serovar typhi
    Baker, Stephen
    Dougan, Gordon
    CLINICAL INFECTIOUS DISEASES, 2007, 45 : S29 - S33
  • [5] Prevalence and antimicrobial susceptibility pattern of Salmonella enterica serovar Typhi and Salmonella enterica serovar Paratyphi among febrile patients at Karamara Hospital, Jigjiga, eastern Ethiopia
    Admassu, Dawit
    Egata, Gudina
    Teklemariam, Zelalem
    SAGE OPEN MEDICINE, 2019, 7
  • [6] Vi Capsular Polysaccharide Produced by Recombinant Salmonella enterica Serovar Paratyphi A Confers Immunoprotection against Infection by Salmonella enterica Serovar Typhi
    Xiong, Kun
    Zhu, Chunyue
    Chen, Zhijin
    Zheng, Chunping
    Tan, Yong
    Rao, Xiancai
    Cong, Yanguang
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2017, 7
  • [7] Adaptive acid tolerance response in Salmonella enterica serovar Typhimurium and Salmonella enterica serovar Typhi
    Tiwari, RP
    Sachdeva, N
    Hoondal, GS
    Grewal, JS
    JOURNAL OF BASIC MICROBIOLOGY, 2004, 44 (02) : 137 - 146
  • [8] Antibiotic susceptibilities of Salmonella enterica serovar Typhi and S-enterica serovar Paratyphi A isolated from patients in Japan
    Hirose, K
    Tamura, K
    Sagara, H
    Watanabe, H
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (03) : 956 - 958
  • [9] Salmonella enterica serovar Paratyphi A and S-enterica serovar Typhi cause indistinguishable clinical syndromes in Kathmandu, Nepal
    Maskey, AP
    Day, JN
    Tuan, PQ
    Thwaites, GE
    Campbell, JI
    Zimmerman, M
    Farrar, JJ
    Basnyat, B
    CLINICAL INFECTIOUS DISEASES, 2006, 42 (09) : 1247 - 1253
  • [10] Fluoroquinolone resistance among Salmonella enterica serovar Paratyphi A in Pondicherry
    Harish, B. N.
    Menezes, G. A.
    Sarangapani, K.
    Parija, S. C.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2006, 124 (05) : 585 - 587